Loading
Latest filing published 17 Oct 2022 for GeneTether Therapeutics Inc., €929.
William James Garner is a declared insider of GeneTether Therapeutics Inc., with filings sourced from SEDI. We count 6 filings; the first trade dates from 21 March 2022 and the latest from 14 October 2022.
No open-market sale appears; the market trades are 3 purchases worth €5,512. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €2,106.
Most recently, on 17 October 2022, the filings show an open-market purchase worth €929 in GeneTether Therapeutics Inc. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations